No Matches Found
No Matches Found
No Matches Found
Beijing Balance Medical Technology Co., Ltd.
Beijing Balance Medical Technology Stock Hits Day Low Amid Price Pressure
Beijing Balance Medical Technology Co., Ltd. saw a significant stock decline today, contrasting with the broader market. Over the past week, the stock has dropped 12.19%, with a year-to-date loss of 23.81%. Long-term trends reveal a 29.1% decrease over three years and a 62.3% drop over five years.
Beijing Balance Medical Technology Hits Day High with 20% Surge
Beijing Balance Medical Technology Co., Ltd. has seen significant intraday activity, reaching a high of CNY 90.72. The stock has risen 6.96% over the past week and 9.91% in the last month, contrasting with broader market trends. However, it faces long-term challenges with a year-to-date decline of 15.22%.
Beijing Balance Medical Technology Hits Day Low Amid Price Pressure at CNY 93.40
Beijing Balance Medical Technology Co., Ltd. faced a significant decline in stock performance, with notable decreases over various time frames. The company has a market capitalization of CNY 13,864 million and a price-to-earnings ratio of 85.00, reflecting challenges in the pharmaceuticals and biotechnology sector.
Beijing Balance Medical Technology Hits Day Low Amid Price Pressure at CNY 100.00
Beijing Balance Medical Technology Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. The company has struggled over the past year, with notable declines in both short-term and long-term metrics, raising concerns about its high valuation despite some positive financial indicators.
Beijing Balance Medical Technology Hits Day Low Amid Price Pressure at CNY 103.47
Beijing Balance Medical Technology Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. Despite a slight weekly recovery, the company has faced a substantial annual decrease, underperforming the market. Financial metrics reveal high valuations and a negative return over the past year, despite increased profits.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
